Programmed cell death in cerebral ischemia

Journal of Cerebral Blood Flow and Metabolism

Volumn 21, Issue 2, 2001, Pages 99-109

  Graham, S H ^a   Chen, J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

AIF; bcl 2; Caspases; Fas; Mitochondria

Indexed keywords

PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; BRAIN INJURY; BRAIN ISCHEMIA; GENE ACTIVITY; GENE CONTROL; GENE TRANSFER; MAMMAL CELL; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; REGULATOR GENE; REVIEW;

EID: 0035122040     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200102000-00001     Document Type: Review

References (85)

1. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures
2. Biochemical pathways of caspase activation during apoptosis
3. Molecular cloning and characterization of rat caspase-activated deoxyribonuclease (CAD)
4. Apoptosis and necrosis after reversible focal ischemia: An in situ DNA fragmentation analysis
5. Characterization of the rat DFF35/ICADs: The endogenous inhibitor of caspase-dependent DNA fragmentation in neuronal apoptosis
6. bcl-2 is expressed in neurons that survive focal ischemia in rat
7. Expression of the apoptosis-effector gene, Bax, is up-regulated in vulnerable hippocampal CA1 neurons following global ischemia
8. Apoptosis repressor genes Bcl-2 and Bcl-x-long are expressed in the rat brain following global ischemia
9. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia
10. Suppression of endogenous bcl-2 expression by antisense treatment exacerbates ischemic neuronal death
11. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury
12. Apoptosis-suppressor gene bcl-2 expression after traumatic brain injury in rats
13. Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia
14. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis
15. Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis?
16. Two C. elegans genes control the programmed deaths of specific cells in the pharynx
17. Genes required for the engulfment of cell corpses during programmed cell death in Caenorhabditis elegans
18. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
19. Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxic-ischemic injury to the developing rat brain
20. Apoptosis control in syncytia induced by the HIV Type 1-Envelope Glycoprotein Complex. Role of mitochondria and caspases
21. Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation
22. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury
23. Altered expression of Bcl-2, Bcl-X, Bax, and c-Fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats
24. Activation of CPP-32 protease in hippocampal neurons following ischemia and epilepsy
25. Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following global ischemia
26. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death
27. Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro
28. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
29. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death
30. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
31. The genetics of programmed cell death in the nematode Caenorhabditis elegans
32. Disturbances of cerebral protein synthesis and ischemic cell death
33. Bax directly induces release of cytochrome c from isolated mitochondria
34. Expression of bcl-2 inhibits necrotic neural cell death
35. Upregulation of Bax protein levels in neurons following cerebral ischemia
36. Expression of caspases and their substrates in the rat model of focal cerebral ischemia
37. Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke
38. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats
39. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
40. Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat
41. Immunoreactivity of cyclin D1/cdk4 in neurons and oligodendrocytes after focal cerebral ischemia in rat
42. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats
43. Expression of bcl-2 from a detective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia
44. The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane
45. Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion
46. Apoptosis inducing factor (AIF): A phylogenetically old, caspase-independent effector of cell death
47. p53 is required for radiation-induced apoptosis in mouse thymocytes
48. Activation of caspase-activated deoxyribonuclease (CAD) mediates DNA fragmentation in mice following transient cerebral ischemia
49. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain
50. Gene expression induced by cerebral ischemia: An apoptotic perspective
51. Cerebral ischemia produces laddered DNA fragments distinct from cardiac ischemia and archetypal apoptosis
52. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia
53. CD95 ligand (Fas-L/APO-IL) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons
54. Ischemic thresholds of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat
55. Bcl-w expression is increased in brain regions affected by focal cerebral ischemia in the rat
56. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
57. Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia
58. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia
59. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria
60. Induction of apoptosis in ischemia-reperfusion model of mouse kidney: Possible involvement of Fas
61. Bcl-2 heterodimerizes in vivo with a conserved homolog. Bax, that accelerates programmed cell death
62. DNA fragmentation follows delayed neuronal death in CA1 neurons exposed to transient global ischemia in the rat
63. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models
64. Bcl-2 and the regulation of programmed cell death
65. Bcl-2 family proteins and mitochondria
66. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat
67. Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation
68. Two CD95 (APO-1/Fas) signaling pathways
69. Extended therapeutic window for caspase inhibition and synergy with MK- 801 in the treatment of cerebral histotoxic hypoxia
70. Sequential metabolic changes in rat brain following middle cerebral artery occlusion: A 2-deoxyglucose study
71. Caspases - Controlling intracellular signals by protease zymogen activation
72. Free radicals, antioxidant enzymes, and carcinogenesis
73. Molecular characterization of mitochondrial apoptosis-inducing factor
74. Two distinct pathways leading to nuclear apoptosis
75. Focal cerebral ischaemia in the rat: 2. Regional cerebral blood flow determined by [14C]iodoantipyrine autoradiography following middle cerebral artery occlusion
76. Caspases: Enemies within
77. Tumor necrosis factor receptor and Fas signaling mechanisms
78. BID: A novel BH3 domain-only death agonist
79. Caspases and neurodegeneration: On the cutting edge of new therapeutic approaches
80. Protective effect of a caspase inhibitor in models for cerebral ischemia in vitro and in vivo
81. NUC-1, a caenorhabditis elegans DNase II homolog, functions in an intermediate step of DNA degradation during apoptosis
82. Overexpression of the cell death suppressor Bcl-w in ischemic brain: Implications for a neuroprotective role via the mitochondrial pathway
83. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
84. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme
85. The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death